188 related articles for article (PubMed ID: 33755692)
1. Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
Louro J; Román M; Posso M; Vázquez I; Saladié F; Rodriguez-Arana A; Quintana MJ; Domingo L; Baré M; Marcos-Gragera R; Vernet-Tomas M; Sala M; Castells X;
PLoS One; 2021; 16(3):e0248930. PubMed ID: 33755692
[TBL] [Abstract][Full Text] [Related]
2. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
Tice JA; Miglioretti DL; Li CS; Vachon CM; Gard CC; Kerlikowske K
J Clin Oncol; 2015 Oct; 33(28):3137-43. PubMed ID: 26282663
[TBL] [Abstract][Full Text] [Related]
3. Differences in breast cancer risk after benign breast disease by type of screening diagnosis.
Louro J; Román M; Posso M; Comerma L; Vidal C; Saladié F; Alcantara R; Sanchez M; Quintana MJ; Del Riego J; Ferrer J; Peñalva L; Bargalló X; Prieto M; Sala M; Castells X
Breast; 2020 Dec; 54():343-348. PubMed ID: 33023825
[TBL] [Abstract][Full Text] [Related]
4. Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
Posso M; Alcántara R; Vázquez I; Comerma L; Baré M; Louro J; Quintana MJ; Román M; Marcos-Gragera R; Vernet-Tomas M; Saladie F; Vidal C; Bargalló X; Peñalva L; Sala M; Castells X;
Eur Radiol; 2022 Jan; 32(1):621-629. PubMed ID: 34156554
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study.
Zhu J; Wang L; Gong W; Li X; Wang Y; Zhu C; Li H; Shi L; Yang C; Du L
Cancer; 2024 Apr; 130(S8):1403-1414. PubMed ID: 37916832
[TBL] [Abstract][Full Text] [Related]
6. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
[TBL] [Abstract][Full Text] [Related]
7. A clinical model for identifying the short-term risk of breast cancer.
Eriksson M; Czene K; Pawitan Y; Leifland K; Darabi H; Hall P
Breast Cancer Res; 2017 Mar; 19(1):29. PubMed ID: 28288659
[TBL] [Abstract][Full Text] [Related]
8. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
Castells X; Torá-Rocamora I; Posso M; Román M; Vernet-Tomas M; Rodríguez-Arana A; Domingo L; Vidal C; Baré M; Ferrer J; Quintana MJ; Sánchez M; Natal C; Espinàs JA; Saladié F; Sala M;
Radiology; 2016 Aug; 280(2):379-86. PubMed ID: 26878225
[TBL] [Abstract][Full Text] [Related]
9. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.
Winkel RR; von Euler-Chelpin M; Nielsen M; Petersen K; Lillholm M; Nielsen MB; Lynge E; Uldall WY; Vejborg I
BMC Cancer; 2016 Jul; 16():414. PubMed ID: 27387546
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.
Castells X; Domingo L; Corominas JM; Torá-Rocamora I; Quintana MJ; Baré M; Vidal C; Natal C; Sánchez M; Saladié F; Ferrer J; Vernet M; Servitja S; Rodríguez-Arana A; Roman M; Espinàs JA; Sala M
Breast Cancer Res Treat; 2015 Jan; 149(1):237-44. PubMed ID: 25503778
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts.
Román M; Hofvind S; von Euler-Chelpin M; Castells X
Br J Cancer; 2019 Jan; 120(2):269-275. PubMed ID: 30563993
[TBL] [Abstract][Full Text] [Related]
12. Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme.
Blanch J; Sala M; Ibáñez J; Domingo L; Fernandez B; Otegi A; Barata T; Zubizarreta R; Ferrer J; Castells X; Rué M; Salas D;
PLoS One; 2014; 9(10):e110207. PubMed ID: 25333936
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
[TBL] [Abstract][Full Text] [Related]
14. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram.
Henderson LM; Hubbard RA; Sprague BL; Zhu W; Kerlikowske K
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1882-9. PubMed ID: 26631292
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.
Puvanesarajah S; Gapstur SM; Gansler T; Sherman ME; Patel AV; Gaudet MM
Cancer Causes Control; 2020 Jan; 31(1):95-103. PubMed ID: 31802322
[TBL] [Abstract][Full Text] [Related]
16. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Rohan TE; Hankinson SE; Marcantonio ER; Ngo LH
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26625899
[TBL] [Abstract][Full Text] [Related]
17. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
[TBL] [Abstract][Full Text] [Related]
18. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.
Eriksson M; Czene K; Strand F; Zackrisson S; Lindholm P; Lång K; Förnvik D; Sartor H; Mavaddat N; Easton D; Hall P
Radiology; 2020 Nov; 297(2):327-333. PubMed ID: 32897160
[TBL] [Abstract][Full Text] [Related]
19. Development and external validation of a breast cancer absolute risk prediction model in Chinese population.
Han Y; Lv J; Yu C; Guo Y; Bian Z; Hu Y; Yang L; Chen Y; Du H; Zhao F; Wen W; Shu XO; Xiang Y; Gao YT; Zheng W; Guo H; Liang P; Chen J; Chen Z; Huo D; Li L;
Breast Cancer Res; 2021 May; 23(1):62. PubMed ID: 34051827
[TBL] [Abstract][Full Text] [Related]
20. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
